Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_assertion type Assertion NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_head.
- NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_assertion description "[In addition, the combination of AICAr with antifolates [methotrexate (MTX) or pemetrexed] has been shown to further potentiate AMPK activation and to lead to greater cytotoxicity and growth inhibition in leukemia and other malignant cell types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_provenance.
- NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_assertion evidence source_evidence_literature NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_provenance.
- NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_assertion SIO_000772 21262957 NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_provenance.
- NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_assertion wasDerivedFrom befree-20140225 NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_provenance.
- NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_assertion wasGeneratedBy ECO_0000203 NP643138.RAStNESnrHWd2Qw-1Ix1-n1TgNFvVdz4JFsjbi52ws4cA130_provenance.